Facial reconstruction

Search LJMU Research Online

Browse Repository | Browse E-Theses

CCL4 induces inflammatory signalling and barrier disruption in the neurovascular endothelium

Estevao, C, Bowers, CE, Luo, D, Sarker, M, Hoeh, AE, Frudd, K, Turowski, P and Greenwood, J (2021) CCL4 induces inflammatory signalling and barrier disruption in the neurovascular endothelium. Brain, Behavior, and Immunity - Health, 18.

CCL4 induces inflammatory signalling and barrier disruption in the neurovascular endothelium.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (3MB) | Preview


Background: During neuroinflammation many chemokines alter the function of the blood-brain barrier (BBB) that regulates the entry of macromolecules and immune cells into the brain. As the milieu of the brain is altered, biochemical and structural changes contribute to the pathogenesis of neuroinflammation and may impact on neurogenesis. The chemokine CCL4, previously known as MIP-1β, is upregulated in a wide variety of central nervous system disorders, including multiple sclerosis, where it is thought to play a key role in the neuroinflammatory process. However, the effect of CCL4 on BBB endothelial cells (ECs) is unknown. Materials and methods: Expression and distribution of CCR5, phosphorylated p38, F-actin, zonula occludens-1 (ZO-1) and vascular endothelial cadherin (VE-cadherin) were analysed in the human BBB EC line hCMEC/D3 by Western blot and/or immunofluorescence in the presence and absence of CCL4. Barrier modulation in response to CCL4 using hCMEC/D3 monolayers was assessed by measuring molecular flux of 70 ​kDa RITC-dextran and transendothelial lymphocyte migration. Permeability changes in response to CCL4 in vivo were measured by an occlusion technique in pial microvessels of Wistar rats and by fluorescein angiography in mouse retinae. Results: CCR5, the receptor for CCL4, was expressed in hCMEC/D3 cells. CCL4 stimulation led to phosphorylation of p38 and the formation of actin stress fibres, both indicative of intracellular chemokine signalling. The distribution of junctional proteins was also altered in response to CCL4: junctional ZO-1 was reduced by circa 60% within 60 ​min. In addition, surface VE-cadherin was redistributed through internalisation. Consistent with these changes, CCL4 induced hyperpermeability in vitro and in vivo and increased transmigration of lymphocytes across monolayers of hCMEC/D3 cells. Conclusion: These results show that CCL4 can modify BBB function and may contribute to disease pathogenesis.

Item Type: Article
Uncontrolled Keywords: BBB, blood-brain barrier; CCL4; CNS, central nervous system; Chemokines; EC, endothelial cell; F-actin, filamentous actin; Inflammation; MAPK, mitogen-activated protein kinase; Neurogenesis; Neuroinflammation; Permeability; SDS-PAGE, Sodium dodecyl sulphate-polyacrylamide gel electrophoresis; VE-cadherin, vascular endothelial cadherin; ZO-1, zonula occludens-1; hCMEC/D3, immortalized human cerebral microvascular endothelial cell line
Subjects: R Medicine > RS Pharmacy and materia medica
Divisions: Pharmacy & Biomolecular Sciences
Publisher: Elsevier
SWORD Depositor: A Symplectic
Date Deposited: 14 Feb 2024 14:57
Last Modified: 14 Feb 2024 15:00
DOI or ID number: 10.1016/j.bbih.2021.100370
URI: https://researchonline.ljmu.ac.uk/id/eprint/22618
View Item View Item